期刊
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
卷 42, 期 8, 页码 369-392出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/jir.2022.0029
关键词
COVID-19; SARS-CoV-2; influenza; flu; cytokine storm; cytokines
资金
- CONACyT from the Fondo Institucional de Fomento Regional para el Desarrollo Cientifico y Tecnologico y de Innovacion (FORDECYT) [FORDECYT/10SE/2020/05/14-06, FORDECYT/10SE/2020/05/14-07]
- Secretaria de Ciencia, Tecnologia e Innovacion de la Ciudad de Mexico (SECTEI CDMX) [SECTEI/050/2020]
- CONACyT [1097402]
There are similarities and differences in the immunopathology of COVID-19 and pandemic influenza. Comparing the cytokine profiles can identify targets for immunotherapy against shared pathogenic mechanisms, while also revealing specific immune alterations exploitable for each infection.
Emerging respiratory viruses are major health threats due to their potential to cause massive outbreaks. Over the past 2 years, the coronavirus disease 2019 (COVID-19) pandemic has caused millions of cases of severe infection and deaths worldwide. Although natural and vaccine-induced protective immune mechanisms against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been increasingly identified, the factors that determine morbimortality are less clear. Comparing the immune signatures of COVID-19 and other severe respiratory infections such as the pandemic influenza might help dissipate current controversies about the origin of their severe manifestations. As such, identifying homologies in the immunopathology of both diseases could provide targets for immunotherapy directed to block shared pathogenic mechanisms. Meanwhile, finding unique characteristics that differentiate each infection could shed light on specific immune alterations exploitable for diagnostic and individualized therapeutics for each case. In this study, we summarize immunopathological aspects of COVID-19 and pandemic influenza from the perspective of cytokine storms as the driving force underlying morbidity. Thereby, we analyze similarities and differences in the cytokine profiles of both infections, aiming to bring forward those molecules more attractive for translational medicine and drug development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据